Military Deployments Delay FDA Studies on LASIK

Copyright Dickinson FDA Webview at www.fdaweb.com. Republished by permission.
9/9/2013

Post-operative quality-of-life studies on military personnel who have undergone LASIK eye surgeries have been delayed indefinitely due to personnel “deployments and the focus of all military staff on the war efforts,” an FDA spokeswoman tells FDA Webview. The study, known as Patient-Reported Outcomes with LASIK (PROWL-1) and commissioned by FDA under a Department of Defense contract to be conducted at the Naval Medical Center San Diego, was announced in 2009 but mysteriously kept under wraps for a year. In October 2010, FDA issued an update estimating that enrollment would begin with three months and completion by the end of 2012.

FDA Webview was told that enrollments for the final, non-military phase of the studies, known as PROWL-2, will be completed in December 2013.

Although activists for injured LASIK patients have shown skepticism about the objectivity of the studies, since Navy ophthalmology surgeons have publicly expressed enthusiasm for the controversial procedure, it is expected that they will shed light on complaints that it leads to a serious adverse reaction rate far higher than the maximum 1% on which FDA approval was based.